» Articles » PMID: 24706837

In Vivo Radiation Response of Proneural Glioma Characterized by Protective P53 Transcriptional Program and Proneural-mesenchymal Shift

Overview
Specialty Science
Date 2014 Apr 8
PMID 24706837
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma is the most common adult primary brain tumor and has a dismal median survival. Radiation is a mainstay of treatment and significantly improves survival, yet recurrence is nearly inevitable. Better understanding the radiation response of glioblastoma will help improve strategies to treat this devastating disease. Here, we present a comprehensive study of the in vivo radiation response of glioma cells in a mouse model of proneural glioblastoma. These tumors are a heterogeneous mix of cell types with differing radiation sensitivities. To explicitly study the gene expression changes comprising the radiation response of the Olig2(+) tumor bulk cells, we used translating ribosome affinity purification (TRAP) from Olig2-TRAP transgenic mice. Comparing both ribosome-associated and total pools of mRNA isolated from Olig2(+) cells indicated that the in vivo gene expression response to radiation occurs primarily at the total transcript level. Genes related to apoptosis and cell growth were significantly altered. p53 and E2F were implicated as major regulators of the radiation response, with p53 activity needed for the largest gene expression changes after radiation. Additionally, radiation induced a marked shift away from a proneural expression pattern toward a mesenchymal one. This shift occurs in Olig2(+) cells within hours and in multiple genetic backgrounds. Targets for Stat3 and CEBPB, which have been suggested to be master regulators of a mesenchymal shift, were also up-regulated by radiation. These data provide a systematic description of the events following radiation and may be of use in identifying biological processes that promote glioma radioresistance.

Citing Articles

Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions.

Bumbaca B, Huggins J, Birtwistle M, Gallo J NPJ Syst Biol Appl. 2025; 11(1):14.

PMID: 39893170 PMC: 11787326. DOI: 10.1038/s41540-025-00493-2.


It's all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma.

Yakubov R, Kaloti R, Persaud P, McCracken A, Zadeh G, Bunda S J Neurooncol. 2025; .

PMID: 39821893 DOI: 10.1007/s11060-024-04930-w.


Mesenchymal Properties of Glioma Cell Lines.

Kholodenko I, Lupatov A, Kim Y, Saryglar R, Kholodenko R, Yarygin K Bull Exp Biol Med. 2024; 178(1):122-129.

PMID: 39585593 DOI: 10.1007/s10517-024-06294-7.


Red light-activated depletion of drug-refractory glioblastoma stem cells and chemosensitization of an acquired-resistant mesenchymal phenotype.

Spring B, Watanabe K, Ichikawa M, Mallidi S, Matsudaira T, Timerman D Photochem Photobiol. 2024; 101(1):215-229.

PMID: 38922889 PMC: 11664018. DOI: 10.1111/php.13985.


The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma.

Wu Q, Berglund A, Macaulay R, Etame A Cells. 2024; 13(11.

PMID: 38891074 PMC: 11171993. DOI: 10.3390/cells13110942.


References
1.
Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

2.
Charles N, Ozawa T, Squatrito M, Bleau A, Brennan C, Hambardzumyan D . Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 2010; 6(2):141-52. PMC: 3818090. DOI: 10.1016/j.stem.2010.01.001. View

3.
Powley I, Kondrashov A, Young L, Dobbyn H, Hill K, Cannell I . Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev. 2009; 23(10):1207-20. PMC: 2685536. DOI: 10.1101/gad.516509. View

4.
Carro M, Lim W, Alvarez M, Bollo R, Zhao X, Snyder E . The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2009; 463(7279):318-25. PMC: 4011561. DOI: 10.1038/nature08712. View

5.
Hu X, Pandolfi P, Li Y, Koutcher J, Rosenblum M, Holland E . mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia. 2005; 7(4):356-68. PMC: 1501155. DOI: 10.1593/neo.04595. View